Answers are grounded in this paper and cite their sources.
Effective strategies to halt tau-driven neurodegeneration in Alzheimer’s disease (AD) remain elusive because approaches that suppress tau kinases often disrupt emotional regulation, resulting in affective disturbances. Here, we show that reduction of DUSP8 drives pathogenic JNK activation in Alzheimer’s tauopathy. DUSP8 is a phosphatase known to preferentially dephosphorylate JNK, and its protein levels are significantly reduced in the hippocampus of 3×Tg-AD mice. This reduction coincides with elevated expression of miR-320-3p (hereafter, miR-320), a microRNA enriched in AD-vulnerable brain regions and predicted to target DUSP8. Hippocampal overexpression of miR-320 induces tau hyperphosphorylation, synaptic dysfunction, and memory deficits. Neuronal knockdown of DUSP8 alone is sufficient to activate JNK and increase tau phosphorylation. Notably, miR-320 overexpression also triggers anxiety- and despair-like behaviors. In contrast, targeted restoration of DUSP8 rescues cognitive and synaptic impairments without causing any detectable affective side effects. Our findings demonstrate that miR-320-dependent reduction of DUSP8 unleashes pathogenic JNK signaling, and establish DUSP8 as a promising precision therapeutic target that enables safe modulation of tau kinase activity in AD.
No takes yet. Share an insight, caveat, or question.
Hu et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: